Table 1.
Control period (24 March to 23 April 2019) | During stay-at-home order (24 March to 23 April 2020) | p value | |
---|---|---|---|
Mean age, years | 72.4 | 65.6 | 0.024 |
Sex | 0.253 | ||
Male | 41/80 (51.3%) | 29/47 (61.7%) | |
Female | 39/80 (48.8%) | 18/47 (38.3%) | |
Race | |||
Caucasian | 74/80 (92.5%) | 41/47 (87.2%) | 0.399 |
African-American | 4/80 (5%) | 3/47 (6.4%) | |
Hispanic | 2/80 (2.5%) | 2/47 (4.3%) | |
Others | 0/80 | 1/47 (2.1%) | |
Stroke risk factors | |||
Hypertension | 51/80 (63.8%) | 35/47 (74.5%) | 0.212 |
Diabetes mellitus | 17/80 (21.3%) | 11/47 (29.8%) | 0.280 |
Atrial fibrillation | 18/80 (22.5%) | 12/47 (29.8%) | 0.698 |
Smoking history | 17/80 (21.3%) | 11/47 (23.4%) | 0.777 |
Low-density lipoprotein notable | 37/80 (46.3%) | 25/47 (53.2%) | 0.450 |
A history of prior stroke | 23/80 (28.8%) | 12/47 (25.5%) | 0.695 |
Stroke subtype | |||
Ischemic stroke | 66/80 (82.5%) | 37/47 (78.7%) | 0.6 |
Hemorrhagic stroke | 12/80 (15.0%) | 9/47 (19.2%) | 0.050 |
Subdural hematoma | 2/80 (2.5%) | 1/47 (2.1%) | 0.629 |
Subarachnoid hemorrhagia | 0/80 | 0/47 | |
Initial NIHSS score | 0.261 | ||
0–4 | 37/66 (56.1%) | 15/36 (41.7%) | |
5–15 | 19/66 (28.8%) | 13/36 (36.1%) | |
16–20 | 3/66 (4.6%) | 5/36 (13.9%) | |
21–42 | 7/66 (10.6%) | 3/36 (8.3%) | |
Difference in LKW and ED time | 0.008 | ||
<4.5 h | 19/58 (32.8%) | 19/36 (52.8%) | |
4.5–12 h | 11/58 (19.0%) | 2/36 (5.6%) | |
12–24 h | 9/58 (15.5%) | 11/36 (30.6%) | |
>24 h | 19/58 (32.8%) | 4/36 (11.1%) | |
Administration of tPA | 13/80 (16.3%) | 14/47 (29.8%) | 0.072 |
tPA time | 0.183 | ||
<90 mins | 0/13 (0%) | 4/14 (28.6%) | |
91–180 mins | 9/13 (69.2%) | 7/14 (50%) | |
181–270 mins | 4/13 (30.8%) | 3/14 (21.4) | |
Large vessel occlusion | 14/80 (17.5%) | 16/47 (34.8%) | 0.028 |
Mechanical thrombectomy | 4/80 (5%) | 14/47 (29.8%) | <0.001 |
Values express n, unless otherwise indicated. COVID-19, 2019-novel Coronavirus; NIHSS, National Institutes of Health Stroke Scale; LKW, last known well; ED, emergency department; tPA, tissue plasminogen activator.